Android app Apple app link

Aclaris Therapeutics, Inc. (ACRS) Analyst Forecast

NASDAQ Currency in USD Disclaimer
Add to Alerts ADD TO LIST

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$2.99
Day's range
$3.4

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date		 Details
09/01/2026 Canaccord Genuity Edward Nash $10.00 $6.05   65.29%
05/05/2026 Piper Sandler Biren Amin $11.00 $4.53   142.83%
04/29/2026 Wedbush Martin Fan $10.00 $4.22   136.97%
01/30/2026 Craig-Hallum Adam Vogel $10.00 $3.43   191.55%
11/19/2024 BTIG Julian Harrison $8.00 $3.14   154.78%
11/19/2024 Jefferies Roger Song $7.00 $3.14   122.93%
11/06/2024 Stifel Nicolaus Alex Thompson $3.00 $2.28   31.87%

Aclaris Therapeutics Inc FAQ's

Aclaris Therapeutics Inc has been rated by research analysts at Canaccord Genuity, Piper Sandler, Guggenheim, Wedbush, UBS, Craig-Hallum in the past 90 days.

Exclusive Content

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.